The ASSCS of ASS-Cleaving Proteases and Insulin-degrading enzyme in the pathogenesis and potential treatment of Alzheimer's disease

old_uid12522
titleThe ASSCS of ASS-Cleaving Proteases and Insulin-degrading enzyme in the pathogenesis and potential treatment of Alzheimer's disease
start_date2013/05/30
schedule11h30
onlineno
detailsSéminaire impromptu. Une invitation de Jean Marc Orgogozo
summaryThe research of Malcolm A. Leissring, Ph.D., is focused on elucidating the molecular pathogenesis of Alzheimer's disease and other age-related neurodegenerative disorders, as well as the fundamental mechanisms underlying aging itself. The primary strengths of Dr. Leissring and his research group lie in discovering and characterizing novel drug targets, validating their suitability as therapies in vivo, and developing novel therapies and therapeutic approaches. Toward these goals, they employ a wide variety of experimental methods ranging from the molecular to the organismal.
responsiblesDeris